Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4, Efficacy and Safety of Sinquanon for Prevention of Antibiotic-associated Diarrhea in Adults in the Out-patient Setting: Prospective, Multicenter, Double-blind, Placebo-controlled Randomized Parallel-arm Clinical Study

NCT05607056 is registered in ClinicalTrials.gov with Neopharm Bulgaria Ltd. as lead sponsor.

NCT NCT05607056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05607056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4, Efficacy and Safety of Sinquanon for Prevention of Antibiotic-associated Diarrhea in Adults in the Out-patient Setting: Prospective, Multicenter, Double-blind, Placebo-controlled Randomized Parallel-arm Clinical Study
Lead sponsor
Neopharm Bulgaria Ltd.
Phase
Not applicable
Overall status
Completed
Start date
November 27, 2022
Completion date
April 25, 2023
Enrollment
565 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic-associated diarrhea